ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Zydus Lifesciences Ltd Complete list of announcements declared & dividend announcements by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences Ltd ZYDUSLIFE listed on NSE and deals in

Announcements and dividends declared by Zydus Lifesciences Ltd ZYDUSLIFE

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 10, 2025, titled "Zydus launches biosimilar Denosumab 120 mg SC protecting bone health in cancer patients".
Announcement as on 10 December 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 09, 2025, titled "Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
Announcement as on 10 December 2025

Zydus Lifesciences introduces biosimilar to protect bone health in cancer patients
Zydus Lifesciences has launched Zyrifa, a Denosumab biosimilar, for treating osteoporosis and preventing skeletal complications in cancer patients. Priced at Rs 12,495, the drug aims to improve access and affordability for patients with bone metastases fro
Announcement as on 10 December 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Zydus receives EIR for the injectable facility located at Jarod".
Announcement as on 04 December 2025

Zydus Lifesciences shares in focus after US FDA nods for diabetes and blood pressure drugs
Zydus Lifesciences is set to be in focus after it received tentative approval from the United States Food and Drug Administration for Empagliflozin and Linagliptin combination tablets for type 2 diabetes, alongside final approval for a blood pressure treat
Announcement as on 28 November 2025

Announcements by Zydus Lifesciences Ltd first page | Next page | Prev page |

ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals

Moving Averages for Zydus Lifesciences Ltd

  • 5Day Average: 919.41
  • 12Day Average: 920.55
  • 20Day Average: 926.62
  • 50Day Average: 949.15
  • 100Day Average: 973.03
  • 150Day Average: 970.26
  • 200Day Average: 948.94

ZYDUSLIFE Indicators & signals

Indicator MACD (12,26,9)

922.17, 930.12, -9.29
Indicator MACD is in negative zone

Indicator ADX (14)

6.8, 17.79, 15.52
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Wed Dec 2025 917.80 916.00 to 937.00 -1.08% 1.39 times
23 Tue Dec 2025 927.80 915.45 to 932.25 1.05% 0.6 times
22 Mon Dec 2025 918.20 917.30 to 928.00 -0.15% 0.89 times
19 Fri Dec 2025 919.60 911.25 to 929.60 0.65% 1.49 times
18 Thu Dec 2025 913.65 909.35 to 918.25 -0.48% 0.65 times
17 Wed Dec 2025 918.10 914.10 to 920.45 0.41% 0.99 times
16 Tue Dec 2025 914.35 912.00 to 928.95 -0.79% 1.4 times
15 Mon Dec 2025 921.60 916.10 to 929.00 -0.81% 0.74 times
12 Fri Dec 2025 929.15 923.05 to 932.00 0.72% 0.81 times
11 Thu Dec 2025 922.55 919.80 to 927.20 -0.11% 0.97 times
10 Wed Dec 2025 923.60 919.00 to 936.45 0.36% 1.46 times
09 Tue Dec 2025 920.25 912.60 to 927.25 -0.47% 2.48 times

Videos related to: ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

 

Back to top